Systemic treatment with proteolytic enzymes in rat models of nonimmune mediated renal diseases

International Journal of Immunotherapy

Volumn 13, Issue 3-4, 1997, Pages 79-83

  Sebekova K ^a   Dammrich J ^b   Fierlbeck, W ^c   Krivosikova Z ^a   Paczek, L ^d   Heidland, A ^b,e  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

^e NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BROMELAIN; CREATININE; PHLOGENZYM; PROTEINASE; RUTOSIDE; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NEPHRECTOMY; NEPHROSCLEROSIS; NONHUMAN; PROTEINURIA; RAT; RENOVASCULAR HYPERTENSION;

EID: 0031399640     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gesualdo L., Ricanati S , Hassan M.O., Emancipator S.N., Lamm M.E Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria and mesangial proliferation in murine experimental IgA nephropathy. J. Clin. Invest., 86, 715, 1990
2. Nakazawa M., Emancipator S.N., Lamm M.E. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in Heymann nephritis. J Exp Med., 164, 1973, 1986
3. Nakazawa M., Emancipator S.N , Lamm M E Removal of glomerular immune complexes in passive serum sickness nephritis by treatment in vivo with proteolytic enzymes. Lab. Invest., 55, 551, 1986.
4. White R.B., Lowne L., Stork J.E., Iskandar S.S., Lamm M.E., Emancipator S.N. Target enzyme therapy of experimental glomerulonephritis in rats. J. Clin. Invest., 87, 1819, 1991.
5. Mai M., Geiger H., Hilgens K.F., et al. Early changes in hypertension induced renal injury. Hypertension, 22, 754, 1993.
6. Heidland A., Ling H , Vamvakas S., Paczek L Impaired proteolytic activity as a potential cause of progressive renal disease. Mineral Electrolyt. Metab., 60, 81, 1996.
7. Schaefer L., Lorenz T., Dämmrich J., Heidland A , Schaefer R M Role of proteinases in renal hypertrophy and matrix accumulation. Nephrol. Dial. Transplant., 10, 801, 1995.
8. Paczek L , Teschner M., Schaefer R M., Kovar J., Romen W., Heidland A. Proteinase activity in isolated glomeruli of Goldblatt hypertensive rats. Clin. Exp. Hyper-Theor. Pract. A., 13(3), 339, 1991.
9. Lehmann P.V. Immunomodulation by proteolytic enzymes. Nephrol. Dial. Transplant , 11, 953, 1996
10. Hale P., Haynes B.F. Bromelin treatment of human T-cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, and Leu8/LAM1 surface molecules and markedly enhances CD-2 mediated T-cell activation. J. Immunol., 129, 3809, 1992.
11. 2-macroglobulin. Immunol. Today, 11, 163, 1990.
12. 2-macroglobulin. J. Biol. Chem., 264, 5818, 1989.
13. 2M. Ann. NY Acad Sci., 737, 245, 1994.
14. Morrison A B. Experimentally induced chronic renal insufficiency in the rat Lab. Invest, 11, 321, 1962.
15. Williams G.R., Harrison T.R., Grollmann A. A simple method for determining the systolic blood pressure in unanesthetised rats. J. Clin. Invest., 18, 373, 1939.
16. Spiro R.G. Studies on the renal glomerular basement membrane. Preparation and chemical composition. J. Biol. Chem., 242, 1915, 1984
17. Barrett A.J., Kirschke H. Cathepsin B, cathepsin H and cathepsin L Meth. Enzymol., 80, 535, 1981
18. Gaciong Z , Paczek L., Bojakowski K., Socha K , Wisniewski M., Heidland A Beneficial effect of protesses on allograft arteriosclerosis in a rar aortic model Nephrol. Dial. Transplant, 11, 987, 1996.